Login / Signup

Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder.

Kazutaka OhiMihoko ShimadaMidori SodaDaisuke NishizawaDaisuke FujikaneKentaro TakaiAyumi KuramitsuYukimasa MutoShunsuke SugiyamaJunko HasegawaKiyoyuki KitaichiKazutaka IkedaToshiki Shioiri
Published in: BMJ mental health (2024)
These findings suggest that the MRS is a potential genetic marker in understanding SZ, particularly in patients with a genetic SZ risk.
Keyphrases
  • genome wide
  • bipolar disorder
  • dna methylation
  • gene expression
  • copy number
  • end stage renal disease
  • major depressive disorder
  • ejection fraction
  • multiple sclerosis
  • peritoneal dialysis
  • brain injury